BRAF and neoplasm: Furthermore, although RET point mutation co-occurs with BRAF V600E mutation, the mutation abundance of BRAF V600E was significantly lower than that of RET point mutation, suggesting that a large proportion of tumor cells have only RET point mutation but no BRAF V600E mutation.